Incretin based therapy for Type 2 Diabetes Mellitus
Journal Title: The Indian Practitioner - Year 2014, Vol 67, Issue 9
Abstract
Type 2 Diabetes Mellitus (T2DM) is associated with obesity, insulin resistance, beta-cell dysfunction and hyperglucagonaemia, leading to hyperglycaemia. With the currently available antidiabetic agents, long term glycaemic control remains poor and attaining a glycosylated Hb (HbA1c) of < 7% is often not achievable. Further the antidiabetic agents available induce weight gain (except metformin), hypoglycaemia and have a negligible effect on beta-cell dysfunction. New classes of drugs that affect incretin hormones show promise in the treatment of T2DM. Incretins i.e. Glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic peptides (GIP) are peptide hormones secreted from the gut in response to ingestion of food and enhance the glucose-stimulated insulin secretion from the pancreas. T2DM patients are resistant to the insulin secreting action of GIP but are responsive to GLP-1. Therefore, GLP-1 shows promise in the treatment of T2DM as it enhances glucose-stimulated insulin secretion and there are less chances of hypoglycaemia. In addition, it promotes insulin biosynthesis, suppresses glucagon secretion, improves fasting and post-prandial blood sugar, HbA1c, inhibits gastric emptying, reduces appetite and food intake. Further, GLP-1 has been found to prevent or reverse the destruction of β cells in preclinical studies and is also associated with beneficial effect on cardio-vascular risk factor including blood pressure (BP), weight, endothelial dysfunction and lipid profiles. The clinical use of GLP-1 is limited by its short t½ of 2 minutes, due to its degradation by the enzyme, dipeptidyl peptidase-4 (DPP-4). To combat this problem, drugs have been developed to increase the level of GLP-1 in the body i.e. GLP-1 receptor agonist (incretin mimetics) and DPP-4 inhibitors (incretin enhancers).
Authors and Affiliations
J Kaur, G Kwatra, DK Badyal
Keywords
Related Articles
- EP ID EP583418
- DOI -
- Views 39
- Downloads 0
Determination of Baseline Widal titres in healthy blood donors from Dhule district
Introduction: Baseline titres to enteric fever pathogens are indicative of the degree of endemicity of infection. The study was conducted for detection of baseline titres for Anti-O and Anti-H for Salmonella typhi and An...
Appraisal of functioning of Janani Suraksha Yojna: A Safe Motherhood Intervention in rural blocks of Haryana
Context: The Government of India had launched Janani Suraksha Yojana (JSY), in the year 2005, as a safe motherhood intervention to reduce maternal and infant mortality rate through better provision and utilisation of Mot...
Spirometric Norms in Healthy Adults of Ahmednagar District of Maharashtra
CONTEXT: Pulmonary function test (PFT) is an invaluable tool for assessment of lung function and is also the investigation of choice for overall assessment of respiratory function. Though its application in diagnosis and...
Disseminated Histoplasmosis
Histoplasmosis is a disease of worldwide occurrence. It is a systemic mycosis caused by Histoplasma capsulatum. Although the majority of cases present as a mild to moderate flulike disease requiring only supportive thera...
The Indian Influenza Outbreak of 2015: Need for caution but not panic !
.